Skip to main content
SpringerLink
Log in

Therapeutic Management and Outcome of Locoregional Recurrence After Curative Colorectal Cancer Therapy—a Single-Center Analysis

  • Original Article
  • Published:
Journal of Gastrointestinal Surgery Aims and scope

Abstract

Locoregional tumor recurrence after curative therapy for colorectal cancer is therapeutically challenging and associated with poor prognosis. Goal of this single-center study was to analyze patients with locoregional recurrence with regard to therapeutic strategies and outcome for colon and rectal cancer each. Charts of all patients surgically treated for colorectal cancer in the period from 2000 to 2011 (n = 1296) were examined; patients with locoregional recurrence (n = 86) were then further analyzed. Fifty-three (10.2 %) patients with rectal and 33 (5.6 %) patients with colon cancer developed a locoregional recurrence, median 24.5 months after first diagnosis. Recurrence-specific therapy was applied in the majority of the patients (84.8 % colon, 90.7 % rectum); a surgical approach was undertaken in 82.1 % (colon) and in 56.3 % (rectum). Five-year overall survival after locoregional recurrence was 13 % for rectal cancer and 9 % for colon cancer. Itemized analysis for the approached therapeutic regimens revealed that radical recurrence resection (R0) significantly prolongs overall survival (p = 0.003) in rectal cancer, as does a surgical approach itself, as compared to conservative treatment modalities. If feasible, oncologic radical resection of the relapse (R0) significantly influences patient outcome and overall survival in rectal cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Boyle P, Levin B. World Cancer Report 2008. WHO press, Geneva

    Google Scholar 

  2. Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray, F. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC Cancer Base No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer; 2013. Available from: http://globocan.iarc.fr, accessed on day/month/year.

  3. Levin B, Lieberman DA, McFarland B, Smith RA, Brooks D, Andrews KS Dash C, Giardiello FM, Glick S, Levin TR, Pickhardt P, Rex DK, Thorson A, Winawer SJ. Screening and Surveillance for the Early Detection of Colorectal Cancer and Adenomatous Polyps, 2008: A Joint Guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. CA Cancer J Clin 2008;58:130–160.

    Article  PubMed  Google Scholar 

  4. Bosetti C, Levi F, Rosato V, Bertuccio P, Lucchini F, Negri E, La Vecchia C. Recent trends in colorectal cancer mortality in Europe. Int. J. Cancer 2011; 129:180–191.

    Article  CAS  PubMed  Google Scholar 

  5. Larkin JO, O’Connell PR . Multivisceral Resection for T4 or Recurrent Colorectal Cancer. Dig Dis 2012;30(suppl 2):96–101.

    Article  PubMed  Google Scholar 

  6. Manfredi S, Bouvier AM, Lepage C, Hatem C, Dancourt V, Faivre J. Incidence and patterns of recurrence after resection for cure of colonic cancer in a well defined population. British Journal of Surgery 2006; 93: 1115–1122.

    Article  CAS  PubMed  Google Scholar 

  7. Lehnert T, Methner M, Pollok A, Schaible A, Hinz U, Herfarth C. Multivisceral Resection for Locally Advanced Primary Colon and Rectal Cancer. An Analysis of Prognostic Factors in 201 Patients. Annals of Surgery 2002; Vol. 235, No. 2, 217–225.

    Article  PubMed Central  PubMed  Google Scholar 

  8. Seo SI, Lim SB, Yoon YS, Kim CW, Yu CS, Kim TW, Kim JH, Kim JC. Comparison of Recurrence Patterns Between ≤ 5 Years and >5 Years After Curative Operations in Colorectal Cancer Patients. Journal of Surgical Oncology 2013;108:9–13.

    Article  PubMed  Google Scholar 

  9. Bowne WB, Lee B, Wong WD, Ben-Porat L, Shia J, Cohen AM, Enker WE, Guillem JG, Paty PB, Weiser MR. Operative Salvage for Locoregional Recurrent Colon Cancer After Curative Resection: An Analysis of 100 Cases. Dis Colon Rectum 2005; 48: 897–909.

    Article  PubMed  Google Scholar 

  10. Kraemer M, Wiratkapun S, Seow-Choen F, Ho YH, Eu KW, Nyam D. Stratifying Risk Factors for Follow-Up: A Comparison of Recurrent and Nonrecurrent Colorectal Cancer. Dis Colon Rectum 2001;44:815–821.

    Article  CAS  PubMed  Google Scholar 

  11. Heald RJ. The ‘Holy Plane’ of rectal surgery. J R Soc Med. 1988,Sep;81(9):503–8.

  12. Wiig JN, Carlsen E, Søreide O. Mesorectal excision for rectal cancer: a view from Europe. Semin Surg Oncol 1998; Sep;15(2):78–86.

  13. Swedish Rectal Cancer Trial. Improved survival with preoperative radiotherapy in resectable rectal cancer. Swedish Rectal Cancer Trial. N Engl J Med. 1997; Apr 3;336(14):980–7.

  14. Kapiteijn E, Kranenbarg EK, Steup WH, Taat CW, Rutten HJ, Wiggers T, van Krieken JH, Hermans J, Leer JW, van de Velde CJ. Total mesorectal excision (TME) with or without preoperative radiotherapy in the treatment of primary rectal cancer. Prospective randomised trial with standard operative and histopathological techniques. Dutch ColoRectal Cancer Group. Eur J Surg. 1999; May;165(5):410–20.

  15. Sauer R, Becker H, Hohenberger W, Rödel C, Wittekind C, Fietkau R, Martus P, Tschmelitsch J, Hager E, Hess CF, Karstens JH, Liersch T, Schmidberger H, Raab R; German Rectal Cancer Study Group. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med. 2004; Oct 21;351(17):1731–40.

  16. Rödel C, Liersch T, Becker H, Fietkau R, Hohenberger W, Hothorn T, Graeven U, Arnold D, Lang-Welzenbach M, Raab HR, Sülberg H, Wittekind C, Potapov S, Staib L, Hess C, Weigang-Köhler K, Grabenbauer GG, Hoffmanns H, Lindemann F, Schlenska-Lange A, Folprecht G, Sauer R; German Rectal Cancer Study Group. Preoperative chemoradiotherapy and postoperative chemotherapy with fluorouracil and oxaliplatin versus fluorouracil alone in locally advanced rectal cancer: initial results of the German CAO/ARO/AIO-04 randomised phase 3 trial. Lancet Oncol. 2012; Jul;13(7):679–87.

  17. Fleming FJ, Påhlman L, Monson JR. Neoadjuvant therapy in rectal cancer. Dis Colon Rectum 2011; Jul;54(7):901–12.

  18. Zitt M, Mühlmann G, Weiss H, Kafka-Ritsch R, Oberwalder M, Kirchmayr W, Margreiter R, Ofner D, Klaus A. Assessment of risk-independent follow-up to detect asymptomatic recurrence after curative resection of colorectal cancer. Langenbecks Arch Surg. 2006; Aug;391(4):369–75.

  19. Kneschaurek P, Wehrmann R, Hugo C, Stepan R, Lukas P, Molls M. The flab method of intraoperative radiotherapy. Strahlenther Onkol. 1995; Feb;171(2):61–9.

  20. Chang KH, Smith MJ, McAnena OJ, Aprjanto AS, Dowdall JF. Increased use of multidisciplinary treatment modalities adds little to the outcome of rectal cancer treated by optimal total mesorectal excision. Int J Colorectal Dis. 2012; Oct;27(10):1275–83.

  21. den Dulk M, Krijnen P, Marijnen CA, Rutten HJ, van de Poll-Franse LV, Putter H, Meershoek-Klein Kranenbarg E, Jansen-Landheer ML, Coebergh JW, van de Velde CJ. Improved overall survival for patients with rectal cancer since 1990: the effects of TME surgery and pre-operative radiotherapy. Eur J Cancer. 2008; Aug;44(12):1710–6.

  22. Kusters M, Marijnen CA, van de Velde CJ, Rutten HJ, Lahaye MJ, Kim JH, Beets-Tan RG, Beets GL. Patterns of local recurrence in rectal cancer; a study of the Dutch TME trial. Eur J Surg Oncol. 2010; May;36(5):470–6.

  23. Sauer R, Liersch T, Merkel S, Fietkau R, Hohenberger W, Hess C, Becker H, Raab HR, Villanueva MT, Witzigmann H, Wittekind C, Beissbarth T, Rödel C. Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO/ARO/AIO-94 randomized phase III trial after a median follow-up of 11 years. J Clin Oncol. 2012; Jun 1;30(16):1926–33.

  24. Kapiteijn E, Marijnen CA, Nagtegaal ID, Putter H, Steup WH, Wiggers T, Rutten HJ, Pahlman L, Glimelius B, van Krieken JH, Leer JW, van de Velde CJ; Dutch Colorectal Cancer Group. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med. 2001; Aug 30;345(9):638–46.

  25. van Gijn W, Marijnen CA, Nagtegaal ID, Kranenbarg EM, Putter H, Wiggers T, Rutten HJ, Påhlman L, Glimelius B, van de Velde CJ; Dutch Colorectal Cancer Group. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial. Lancet Oncol. 2011; Jun;12(6):575–82.

  26. Mirnezami AH, Sagar PM, Kavanagh D, Witherspoon P, Lee P, Winter D. Clinical algorithms for the surgical management of locally recurrent rectal cancer. Dis Colon Rectum. 2010; Sep;53(9):1248–57.

  27. Reerink O, Mulder NH, Botke G, Sluiter WJ, Szabó BG, Plukker JT, Verschueren RC, Hospers GA. Treatment of locally recurrent rectal cancer, results and prognostic factors. Eur J Surg Oncol. 2004; Nov;30(9):954–8.

  28. Miller AR. Multidisciplinary management of recurrent colorectal cancer. Surg Oncol. 1998; Nov-Dec;7(3–4):209–21.

  29. Harji DP, Griffiths B, McArthur DR, Sagar PM. Surgery for recurrent rectal cancer: higher and wider? Colorectal Dis. 2013; Feb;15(2):139–45.

  30. Hyngstrom JR, Tzeng CW, Beddar S, Das P, Krishnan S, Delclos ME, Crane CH, Chang GJ, You YN, Feig BW, Skibber JM, Rodriguez-Bigas MA. Intraoperative radiation therapy for locally advanced primary and recurrent colorectal cancer: Ten-year institutional experience. J Surg Oncol. 2014; Jun;109(7):652–8.

  31. Asoglu O, Karanlik H, Muslumanoglu M, Igci A, Emek E, Ozmen V, Kecer M, Parlak M, Kapran Y. Prognostic and predictive factors after surgical treatment for locally recurrent rectal cancer: a single institute experience. Eur J Surg Oncol. 2007; Dec;33(10):1199–206.

  32. Harji DP, Sagar PM, Boyle K, Griffiths B, McArthur DR, Evans M. Surgical resection of recurrent colonic cancer. Br J Surg. 2013; Jun;100(7):950–8.

Download references

Author information

Authors and Affiliations

  1. Department of Visceral, Transplant and Thoracic Surgery, Center of Operative Medicine, Innsbruck Medical University, Anichstrasse 35, A-6020, Innsbruck, Austria

    Pamela Kogler, Reinhold Kafka-Ritsch, Johann Pratschke & Matthias Zitt

  2. TiRoLab, Wattens, Austria

    Michael Sieb

  3. Department of Therapeutic Radiology and Oncology, Innsbruck Medical University, Innsbruck, Austria

    Arpad Sztankay

Authors
  1. Pamela Kogler
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Reinhold Kafka-Ritsch
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Michael Sieb
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Arpad Sztankay
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Johann Pratschke
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Matthias Zitt
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Matthias Zitt.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kogler, P., Kafka-Ritsch, R., Sieb, M. et al. Therapeutic Management and Outcome of Locoregional Recurrence After Curative Colorectal Cancer Therapy—a Single-Center Analysis. J Gastrointest Surg 18, 2026–2033 (2014). https://doi.org/10.1007/s11605-014-2633-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11605-014-2633-y

Keywords

Search

Navigation